S&P 500 slips, but losses kept in check as Nvidia climbs ahead of results
In a recent filing with the Securities and Exchange Commission, Orthopediatrics Corp (NASDAQ:KIDS), a company currently valued at $614 million with a "GOOD" InvestingPro Financial Health score, disclosed that Fred Hite, the company’s Chief Operating Officer and Chief Financial Officer, sold 6,443 shares of common stock on March 18, 2025. The shares were sold at a price of $24.86 each, totaling approximately $160,172.
This transaction follows an acquisition of 63,342 shares on March 15, 2025, which were obtained without any monetary exchange. After these transactions, Hite holds a total of 207,989 shares, including restricted stock awards totaling 150,360 shares. The recent sale was conducted to satisfy tax withholding obligations upon the vesting of restricted shares. The company maintains strong liquidity with a current ratio of 6.98 and operates with moderate debt levels, though analysts anticipate continued unprofitability in the current fiscal year.
In other recent news, OrthoPediatrics Corporation reported its fourth-quarter 2024 earnings, revealing a larger-than-expected loss with an EPS of -$0.69, missing the forecasted -$0.30. However, the company’s revenue of $52.7 million exceeded expectations of $50.72 million, marking a 40% year-over-year increase. The U.S. revenue saw a significant 52% rise, contributing to the overall revenue growth. For 2025, OrthoPediatrics projects revenue between $235 million and $242 million, representing a 15-18% growth. Stifel analysts have adjusted the price target for OrthoPediatrics to $32.00 from $40.00, maintaining a Buy rating, reflecting a positive outlook despite the earnings miss. Management has highlighted several key sales drivers for 2025, including expanding the Specialty Bracing franchise and a strong U.S. Trauma business. These developments suggest potential market share gains and a broadening product portfolio. Additionally, OrthoPediatrics anticipates achieving its first positive free cash flow by Q4 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.